Janos brings with him a well-rounded set of skills in medical, sales, business development, finance and administration which combined are instrumental for Extrovis’ commercial and partnership strategy and support the definition of the company’s portfolio and execution of the development projects.
Before joining Extrovis in Switzerland he held various general management and P&L responsibilities at Amneal based in Switzerland, Alliance Healthcare (now part of Walgreens Boots Alliance), ratiopharm (now part of the Teva Group) and Sanofi.
Janos has a Summa Cum Laude degree from the Szent-Györgyi Albert Medical University in Szeged, Hungary.
The Chief Strategic Officer at Extrovis, Hanumantha has a master’s degree in International Management from Pondicherry Central University, India. He combines a strong knowledge of industry trends and portfolio strategy with a vast professional network. Prior to his role at Extrovis Switzerland, Hanumantha held various managerial positions in the areas of strategic sourcing, portfolio management and strategic business development at Amneal, Ranbaxy and Dr. Reddy’s.
Mathijs Steegstra has worked in the pharmaceutical industry for almost 20 years, always in Quality and Regulatory roles covering USA, Europe and MENA.
With experience in both innovator and generics, he has set up RA infrastructures for newly formed companies and optimized them for established companies. He obtained multiple Marketing Authorization approvals for various types of products ranging from NCE’s to repurposed molecules to complex generics.
He was responsible for the quality of multiple sites, including sterile production sites and has handled remediation projects for several sites.
Originally from the Netherlands, he studied pharmacy at the University of Groningen and holds a pharmacists degree, specializing in molecular pharmacology.
Sreevatsa Natarajan (Vatsa) brings to Extrovis more than two decades of experience from the areas of drug discovery and development, program and alliance management, business development and licensing collected at renowned multinational organizations like Vertex Pharma, Glenmark Pharma, Dr Reddy’s Labs and Rhizen Pharma. He brings rich global managerial and entrepreneurial experience at the science-business interface in translating scientific ideas into successful products & licensing deals and has co-founded & led a bio-bank that supports drug & biomarker discovery. Vatsa holds graduate degrees in chemistry and biopharmaceutics from BITS Pilani, India and Virginia Commonwealth University, Richmond VA, USA.
Dr. Rajasekhara brings to Extrovis over 15 years of research and development experience in complex genetics, including but not limited to liposomal, microsphere and nanoparticle technology, and drug device combinations. With a PhD in Pharmaceutical Sciences and the co author of several scientific publications, Dr. Rajasekhara has held various R&D management positions at renowned companies such as Alembic, Hospira, Leiutis, Dr. Reddy’s and Gland. Here at Extrovis, he is focused on leading the company’s efforts to ideate and implement a robust complex generics portfolio.
As Chief Scientific Officer at Extrovis, Dr. Hanumantharao brings over 20 years of experience and expertise in process research and development, API manufacturing and technology transfer, and is responsible for the robust execution of API development programmes for Extrovis. He has held various management positions at reputed pharmaceutical companies such as Aurobindo, Azico Biophors and Caplin Point. His impressive academic background, which includes a PhD degree in organic chemistry and a co-authors title for several scientific publications, underpins his scientific knowledge with his acute business acumen and expertise in managing research and development organisations.
A graduate in veterinary sciences from one of India’s top leading institutions, Dr. Mallikarjun has spent over two decades in animal healthcare and service. His passion for healthcare and stellar record as a leader in previous projects brings great value. Dr. Mallikarjun has assumed the position of Head of India operations at Extrovis AG.